Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Cerritos. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Cerritos at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this multiple myeloma clinical trial in Cerritos, CA
If you're searching for multiple myeloma treatment options in Cerritos, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cerritos research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.